MedicTech Solutions

Startpagina
België
Merchtem
MedicTech Solutions

Contactgegevens, kaart en routebeschrijving, contactformulier, openingstijden, diensten, beoordelingen, foto's, video's en aankondigingen van MedicTech Solutions, Farmaceutisch bedrijf, gasthuisstraat 24, Merchtem.

13/06/2023

The animated heart anatomy model is a game-changer in medical education and research. With stunning detail and accuracy, it provides an immersive and interactive learning experience for students and professionals alike.

From the intricate structure of the heart's chambers and valves to the complex network of blood vessels that supply oxygen and nutrients to the body, the model is a true marvel of engineering and design.

But what truly sets it apart is its ability to demonstrate the heart's functionality in real-time. The beating of the heart and the flow of blood through the circulatory system are brought to life, providing a deeper understanding of the physiology behind the cardiovascular system.

The model is not just a static representation of the heart, but a dynamic and engaging tool that can help medical professionals and students alike better understand this critical organ and its role in overall health.

01/04/2023

MedicTechSolutions attended CETA 5 year anniversary. CETA represents more than just a trade agreement. It’s a platform for partnership for Canada and the EU to engage on a wide range of economic and strategic issues. Attending the 5year anniversary of CETA was a great opportunity for MedicTechSolutions to network and prospect new collaborations and partnerships opportunities with other companies and organizations, learn and understand the economic and trade agreement between the Canada and the EU. MedicTech Solutions and our Experts are ready to contribute to the ongoing dialogue between Canada and the EU and help shape the future of the partnership.

25/03/2023

Did you know In the early 2000s, Biogen was facing a major setback. One of their key products, a multiple sclerosis drug called Tysabri, was linked to a rare but potentially deadly brain infection. Biogen had to pull the drug from the market and face the possibility of losing billions of dollars in revenue.
Instead of giving up, Biogen's scientists and researchers went back to the drawing board. They developed a sophisticated screening process to identify patients who were at lower risk of the brain infection and were more likely to benefit from Tysabri. In 2006, the drug was reintroduced to the market with new safety measures in place.
The gamble paid off. Today, Tysabri is one of Biogen's top-selling products and is helping thousands of patients with multiple sclerosis worldwide.

Multiple sclerosis (MS) is a chronic and often disabling disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. MS is considered an autoimmune disease, which means that the body's immune system mistakenly attacks and damages the myelin sheath, a protective layer that covers nerve fibers in the CNS. The damage to the myelin sheath disrupts the transmission of nerve impulses between the brain and the rest of the body, leading to a wide range of symptoms that can include:
Vision problems, such as blurred vision, double vision, or loss of vision
Muscle weakness and stiffness
Coordination and balance problems
Sensory changes, such as numbness or tingling in the arms, legs, or face
Fatigue
Cognitive impairment, such as problems with memory, attention, and problem-solving
Emotional changes, such as depression or mood swings

Biogen's ability to turn a setback into a success is a testament to the company's commitment to patient-centered innovation and determination to overcome obstacles in the pursuit of better healthcare outcomes.

21/03/2023

MedicTechSolutions attended The UK Innovation & Tech Show organised by UK mission to the EU brought together innovators, companies and thought leaders from across the UK and Europe for a stunning exhibition and a series of policy discussions around cutting edge technologies.

12/03/2023

Last Year in November we were at The European Alliance for Cardiovascular Health (EACH) were they brought together key stakeholders active in the field of cardiovascular health , national policy makers, cardiovascular patients in the EU parliament to discuss how the EU can act to improve cardiovascular health for all, the 60 million people in Europe suffering from a cardiovascular disease today, and the millions of people that are living with a cardiovascular disease without being diagnosed.

12/03/2023

Last year in December we attended a Great panel organised by European Business Summits for the European health summit HOW TO BUILD A SUSTAINABLE R&D ECOSYSTEM FOR RARE DISEASES with experts like Dirk Vander Mijnsbrugge(Vice president Phizer) Amanda Bok (CEO European Haemophilia Consortium) Daria Julkowska (PHD assistant Director Thematic institute of genetics, Genomics& Bioinformatics France) Andrew Thomson ( Statistician European Medicines Agency)

To build a sustainable research and development (R&D) ecosystem for rare diseases, several steps can be taken. Some potential strategies include:

Investing in research: To support the development of new treatments and therapies for rare diseases, it is important to invest in research. This can involve providing funding for academic and industry researchers, as well as supporting the development of new technologies and approaches.

Engaging with patients and advocacy groups: To ensure that R&D efforts are focused on the needs of patients with rare diseases, it is important to engage with these stakeholders. This can involve involving patients and advocacy groups in the research process, as well as providing support and resources to help them participate in clinical trials and other research activities.

Collaborating with other stakeholders: To build a sustainable R&D ecosystem for rare diseases, it is important to engage with a range of stakeholders, including healthcare providers, regulators, and industry partners. By working together, these groups can support the development of new treatments and therapies, as well as help to identify and address any challenges or barriers to progress.

Promoting awareness and education: Raising awareness about rare diseases and the importance of R&D in this area can help to support a sustainable ecosystem. This can involve providing education and resources to patients and caregivers, as well as promoting public awareness of rare diseases and the need for continued investment in research and development.

Overall, to build a sustainable R&D ecosystem for rare diseases, it is important to invest in research, engage with patients and advocacy groups, collaborate with other stakeholders, and promote awareness and education.

09/03/2023

It was great to attend The Masters of Digital Event organised by DIGITALEUROPE interesting insights from the panel discussion about the European Health Data Space. It's clear that there is a growing recognition of the potential benefits of creating a European health data space that enables efficient and secure access to health data across borders for research and innovation purposes.
It's encouraging to hear that patient data protection is also being taken seriously, with a focus on empowering patients to become the owners of their own health data. Additionally, there is a recognition of the importance of establishing trust through transparency in how the data is used and investing in health. also exciting to hear the potential for healthcare systems to follow up with patients and use data to discover early interventions, better treatments and preventions, especially in areas like Cardio vascular disease, breast and lung cancer, Lymphoma,Leukemia etc. to hear about Precision medicine and sharing data to advance scientific progression as critical areas of focus that can benefit from a European health data space.
Overall, it's clear that data collection and use are essential for advancing healthcare and intervening early to change the trajectory of diseases. It's heartening to see a growing emphasis on collaboration and the need for a team sport approach to make progress in this critical area.

Adres

Gasthuisstraat 24
Merchtem
1785

Website

http://MedicTechSolutions.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer MedicTech Solutions nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Video's

The animated heart anatomy model is a game-changer in medical education and research. With stunning detail and accuracy, it provides an immersive and interactive learning experience for students and professionals alike. From the intricate structure of the heart's chambers and valves to the complex network of blood vessels that supply oxygen and nutrients to the body, the model is a true marvel of engineering and design. But what truly sets it apart is its ability to demonstrate the heart's functionality in real-time. The beating of the heart and the flow of blood through the circulatory system are brought to life, providing a deeper understanding of the physiology behind the cardiovascular system. The model is not just a static representation of the heart, but a dynamic and engaging tool that can help medical professionals and students alike better understand this critical organ and its role in overall health. #HeartAnatomy #CardiovascularSystem #InteractiveLearning #MedicalResearch #Healthcare #AnatomyModel #MedicalTechnology #Physiology #MedicalScience #EducationRevolution #Innovation #ResearchAdvancements #biotechnologylab #medicalanimation #molecularbiology #heart

Did you know In the early 2000s, Biogen was facing a major setback. One of their key products, a multiple sclerosis drug called Tysabri, was linked to a rare but potentially deadly brain infection. Biogen had to pull the drug from the market and face the possibility of losing billions of dollars in revenue. Instead of giving up, Biogen's scientists and researchers went back to the drawing board. They developed a sophisticated screening process to identify patients who were at lower risk of the brain infection and were more likely to benefit from Tysabri. In 2006, the drug was reintroduced to the market with new safety measures in place. The gamble paid off. Today, Tysabri is one of Biogen's top-selling products and is helping thousands of patients with multiple sclerosis worldwide. Multiple sclerosis (MS) is a chronic and often disabling disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. MS is considered an autoimmune disease, which means that the body's immune system mistakenly attacks and damages the myelin sheath, a protective layer that covers nerve fibers in the CNS. The damage to the myelin sheath disrupts the transmission of nerve impulses between the brain and the rest of the body, leading to a wide range of symptoms that can include: Vision problems, such as blurred vision, double vision, or loss of vision Muscle weakness and stiffness Coordination and balance problems Sensory changes, such as numbness or tingling in the arms, legs, or face Fatigue Cognitive impairment, such as problems with memory, attention, and problem-solving Emotional changes, such as depression or mood swings Biogen's ability to turn a setback into a success is a testament to the company's commitment to patient-centered innovation and determination to overcome obstacles in the pursuit of better healthcare outcomes. #research #development #biogen #Biogen #biotech #neurology #immunology #MultipleSclerosis #innovation #research #healthca

DIDUSTARLIGHTING

LED LIGHTING SOLUTION We offer high-quality LED products with very competitive prices that can reduce your energy costs, making now the ideal time to replace your old bulbs with our products. https://www.didustar.com/

Available lights in our store including LED Super slim panel Light product features: .Light sources : LED SMD .Power Supply: lamps and lanterns with external constant current power supply of high conversion rate .Material : Aluminium /PC Main applications : commercial shops , Hotels , Exhibition halls , art rooms , offices , homes etc . Contact info Yannick : 0499896050 for more information!